.png)
Which would you prefer to have?
Good Products and Services
OR
Bad Products and Services
So why would you ever think your customer wants a bad product or service from your company?
You probably never realized the following:
GOOD PRODUCTS AND SERVICES = GOOD QUALITY = LESS PROBLEMS + MORE PROFIT
BAD PRODUCTS AND = BAD QUALITY = MORE PROBLEMS + LESS PROFIT
So, what is quality?
I like the brand!
I trust the brand!
I like the box!
My mother uses it!
My friend uses it! My doctor says so!
The pharmacist sells it!
Quality is the perception of the degree to which the product or service meets the customer's expectations. Besides quality, there is quality control (i.e. the detection of defects) and quality assurance (i.e. the prevention of defects).
The key quality concept for all manufacturers and service providers is ‘Say what I do and do what I say’.
Typically, what occurs for a company to have good products and services is to establish a quality management system. A quality management system is a keen business approach mandated by top management to satisfy the particular safety and performance needs of a specific manufacturer, product, service, and user-market that (a) extends from customer requirements through development and production to customer use and feedback and (b) encompasses the appropriate laws and regulations.
There is a catch. For a company to have good quality products and services, there needs to be a balance between a company’s internal mission, vision, objectives, goals, and strategies and governmental and industrial laws, regulations, directives, standards, guidance, and other requirements while also meeting the needs of internal and external stakeholders of the company.
However, for the Cannabis industry this balancing act is currently on the side of the internal stakeholders and certain external stakeholders (such as suppliers and customers).
The reason has to do with the creation, implementation, and enforcement of local, state, regional, national, and international governmental and industrial laws, regulations, directives, standards, guidance, and other requirements.
For example, in the United States, the federal government does not allow any cannabis products or products containing any cannabis derivatives, such as THC (tetrahydrocannabinol) or CBD (cannabidiol) to be sold in interstate commerce.
You may have heard about the Agriculture Improvement Act of 2018 (Farm Bill) that removed cannabis and cannabis derivatives that are very low in THC from the definition of marijuana in the Controlled Substances Act (CSA).
Even though the 2018 Farm Bill caused the definition of marijuana to be revised, certain federal governmental agencies (such as the U.S. Food and Drug Administration, aka FDA) still disallow products containing cannabis or cannabis-derived compounds, including cannabidiol (CBD), to be distribued in U.S. interstate commerce. There are a few exemptions, such as certain hemp products on FDAs GRAS (Generally Recommended As Safe) list [i.e. hulled hemp seed (GRN765), hemp seed protein powder (GRN771), and hemp seed oil (GRN778)] and the 2018 FDA approval of the Rx pharmaceutical Epidiolex (i.e. a purified form of CBD for use in the treatment of certain seizure disorders).
As explained above, only three (3) hemp products are currently on FDA’s GRAS list and one pharmaceutical product containing CBD has been approved as safe and effective to date. However, this does not mean that products with cannabis-derived compounds will not be allowed to be marketed between the states. Once the FDA has received scientific data from human and animal food, cosmetic, drug, medical device, biologic, and combination product companies about the safety and efficacy of their while weighing the product and health safety and risks, will additional FDA regulated products be allowed to be marketed through interstate commerce.
However, why are companies in the United States now allowed to manufacture and sell all types of drugs, food, dietary supplements, cosmetics, pet food, and other animal health products that contain THC (tetrahydrocannabinol) or CBD (cannabidiol) within the U.S. marketplace? It has to do with the separation of powers between the U.S. federal government and the 50 state governments.
On the state level, some jurisdictions have eliminated certain prohibitions on cannabis or cannabis-derived compounds. What this means is that more and more cannabis products are being manufactured and marketed (either legally or illegally) within certain state borders.
As such, until science and the governmental laws catch up to society’s need for cannabis and products containing cannabis or cannabis-derived compounds, we at iCAN GMP caution the consumer.
This is because while there are legitimate growers, manufacturers, testing facilities, and distributors, there are also illegal and immoral people with questionable companies, products, and services, who are jumping on the bandwagon while profiting from the success of legitimate companies and services and the ignorance of the consumers. It is these horrific people that will indeed pay the price once enforcement actions occur by local, state, and federal governments.
One way iCAN GMP is preventing these people from benefitting from the hard work of true quality minded entrepreneurs, is to allow us to work with you and develop a proven quality auditing system with approved suppliers and contractors.
Comentarios